摘要
Hubei Biocause Pharmaceutical Co.,Ltd. (Biocause,SZ:000627)announced on October 27th to invest RMB302 million in buildinga new propylene project.The proposed propylene project is to offer propylene to its20 000 t/a polypropylene facility,aiming at ensuring feedstocksupply,expanding portfolio and cutting production cost.The new propylene project will use C4 olefins as raw